-
141
Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
Published 2022-07-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
142
On improving the safety of new direct acting oral anticoagulants
Published 2018-02-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
143
MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS
Published 2018-09-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
144
Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
Published 2023-03-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
145
Analysis of the Causes for Renal Dysfunction during Antibiotic Therapy in a Patient with Lyme Disease
Published 2022-10-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
146
Strategy of Rational Therapy of Acute Respiratory Infections in Patients with Comorbidity
Published 2020-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
147
Drug Allergy in Adults at a Multidisciplinary Hospital: Prevalence Assessment Using the Global Trigger Tool
Published 2022-03-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
148
Drug Safety Monitoring—International Information
Published 2020-12-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
149
Structure of Adverse Events Following Immunisation against Coronavirus Infection (COVID-19) in the Kyrgyz Republic
Published 2022-12-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
150
Information for authors
Published 2018-02-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
151
Analysis of Errors Identified during Regulatory Review of Risk Management Plans Submitted as Part of Registration Dossiers
Published 2023-12-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
152
Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
Published 2022-04-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
153
The Adverse Drug Reactions Registered During the Postmarketing Period
Published 2019-03-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
154
Thank You to All Our Reviewers
Published 2022-12-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
155
Conducting Pharmaceutical Inspections in the Russian Federation to Ensure Compliance with the EAEU GCP Requirements Is an Accepted Necessity
Published 2023-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
156
Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
Published 2020-12-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
157
Drug-induced liver injuries in pregnancy in the context of polypragmasy
Published 2018-02-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
158
Analysis of the Clinical Case of Long-term Monitoring of a Patient with Comorbid Depression: Special Considerations of Psychopharmacotherapy
Published 2020-06-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
159
Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
Published 2019-09-01“…Безопасность и риск фармакотерапии…”
Get full text
Article -
160
Antimicrobial Resistance: A Risk Factor for the Biosafety System
Published 2023-09-01“…Безопасность и риск фармакотерапии…”
Get full text
Article